CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis
Rachel E. Miller(Northwestern University), Anne‐Marie Malfait(Rush University Medical Center), Rosalina Das(Center for Rheumatology), Nayereh Ghoreishi‐Haack(Abbott Fund), Phuong B. Tran(Center for Rheumatology), Richard J. Miller(Northwestern University), Dongjun Ren(Northwestern University)
Cited by 289
Related Papers
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|770
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
|Proceedings of the National Academy of Sciences|2000|662
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
|Osteoarthritis and Cartilage|2001|324
Osteoarthritis joint pain: The cytokine connection
|Cytokine|2014|321